Real-world effectiveness and safety of sofosbuvir and nonstructural protein 5A inhibitors for chronic hepatitis C genotype 1, 2, 3, 4, or 6: a multicentre cohort study

BACKGROUND: We investigated real-world effectiveness and safety of sofosbuvir and the nonstructural protein 5A inhibitors in the treatment of patients infected with hepatitis C virus (HCV) genotypes 1, 2, 3, 4, or 6. METHODS: We analyzed data from 1021 patients with HCV infection (506 with genotype...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:BMC Gastroenterol
Main Authors: Charatcharoenwitthaya, Phunchai, Wongpaitoon, Virasak, Komolmit, Piyawat, Sukeepaisarnjaroen, Wattana, Tangkijvanich, Pisit, Piratvisuth, Teerha, Sanpajit, Theeranun, Sutthivana, Chinnavat, Bunchorntavakul, Chalermrat, Sobhonslidsuk, Abhasnee, Chonprasertsuk, Soonthorn, Siripipattanamongkol, Chotipong, Sethasine, Supatsri, Tanwandee, Tawesak
Formato: Artigo
Idioma:Inglês
Publicado em: BioMed Central 2020
Assuntos:
Research Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC7057522/
https://ncbi.nlm.nih.gov/pubmed/32138687
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12876-020-01196-0
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados